Literature DB >> 19885307

Are all clinical studies sponsored by industry not valid?

Lutz Heinemann1.   

Abstract

Industry-sponsored studies have such a bad reputation that some journals require an additional statistical analysis by an independent statistician. This commentary discusses some of the reasons why academic people tend to believe that "academic" science is better than industry-driven science. Most likely, when it comes to publications, the risk of fraud exists in both worlds as the pressure to publish "significant" data is prevalent in both worlds. In contrast to the academic world, the level of control by regulatory bodies for industry-sponsored studies is much higher. Therefore, the quality of industry-driven studies is high, at least when it comes to the quality of data. One of the main reasons why academic people are so skeptical about the pharmaceutical industry is a lack of knowledge about the work done in industry. It is as demanding and scientific as in other industries. In turn, many physicians working in the pharmaceutical industry have low self-esteem. Also, the pharmaceutical industry should improve its self-presentation adequately to get rid of its bad image. There is a clear need for more communication between both worlds in order to better understand the mutual difficulties and needs.

Entities:  

Keywords:  authorship; clinical studies; good clinical practice; pharmaceutical industry

Year:  2008        PMID: 19885307      PMCID: PMC2769827          DOI: 10.1177/193229680800200627

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  2 in total

1.  Publication fraud, dishonesty, and deceit.

Authors:  Chad Cook
Journal:  J Man Manip Ther       Date:  2012-05

Review 2.  Economics of obesity--learning from the past to contribute to a better future.

Authors:  Jaithri Ananthapavan; Gary Sacks; Marj Moodie; Rob Carter
Journal:  Int J Environ Res Public Health       Date:  2014-04-14       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.